| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
11,311 |
6,298 |
$382K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
996 |
626 |
$49K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
452 |
332 |
$41K |
| 80053 |
Comprehensive metabolic panel |
13,957 |
7,704 |
$40K |
| 80061 |
Lipid panel |
7,945 |
4,763 |
$35K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,276 |
4,830 |
$34K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,928 |
2,308 |
$32K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
193 |
143 |
$25K |
| 71250 |
|
491 |
397 |
$24K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,329 |
4,439 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
1,949 |
1,426 |
$20K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
567 |
379 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,475 |
5,299 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,365 |
899 |
$18K |
| 76642 |
|
684 |
395 |
$17K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,694 |
3,565 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
19,917 |
11,012 |
$16K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
970 |
687 |
$14K |
| 77065 |
Tomosynthesis, mammo |
265 |
165 |
$12K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
217 |
148 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,218 |
828 |
$11K |
| 84439 |
|
3,410 |
2,016 |
$11K |
| 82728 |
|
2,577 |
1,533 |
$11K |
| 82607 |
|
2,357 |
1,375 |
$10K |
| 84466 |
|
2,254 |
1,346 |
$9K |
| 77066 |
Tomosynthesis, mammo |
143 |
97 |
$8K |
| 85027 |
|
3,887 |
2,303 |
$8K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
752 |
459 |
$6K |
| 83540 |
|
2,434 |
1,451 |
$5K |
| 82746 |
|
1,568 |
918 |
$5K |
| 80050 |
General health panel |
1,496 |
825 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,488 |
791 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
58 |
48 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
119 |
81 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
726 |
442 |
$3K |
| 72110 |
|
163 |
126 |
$3K |
| 84481 |
|
477 |
307 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,807 |
1,096 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
57 |
44 |
$3K |
| 76770 |
|
78 |
62 |
$3K |
| 81001 |
|
2,335 |
1,382 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
488 |
333 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
356 |
212 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
249 |
152 |
$2K |
| 82570 |
|
1,202 |
706 |
$2K |
| 73560 |
|
176 |
102 |
$2K |
| 84153 |
|
363 |
224 |
$2K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
21 |
12 |
$2K |
| 82043 |
|
858 |
529 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
73 |
40 |
$1K |
| 86780 |
|
259 |
169 |
$1K |
| 87077 |
|
836 |
458 |
$997.79 |
| 85610 |
|
717 |
416 |
$982.25 |
| 73030 |
|
112 |
75 |
$905.90 |
| 76536 |
|
52 |
36 |
$893.28 |
| 86140 |
|
515 |
287 |
$854.18 |
| 86803 |
|
246 |
160 |
$821.52 |
| 86038 |
|
219 |
114 |
$764.01 |
| 87070 |
|
478 |
279 |
$722.04 |
| 83970 |
|
40 |
24 |
$697.62 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
81 |
42 |
$689.00 |
| 85652 |
|
677 |
372 |
$521.60 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
55 |
30 |
$516.75 |
| 83735 |
|
297 |
152 |
$506.71 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
29 |
14 |
$444.60 |
| 87186 |
|
280 |
174 |
$430.35 |
| 0353U |
|
77 |
55 |
$358.50 |
| 77062 |
|
24 |
14 |
$346.22 |
| 87150 |
|
71 |
60 |
$333.81 |
| 86618 |
|
77 |
38 |
$332.85 |
| 87340 |
|
115 |
72 |
$297.90 |
| 73630 |
|
26 |
13 |
$295.65 |
| 72081 |
|
21 |
12 |
$272.41 |
| 85730 |
|
133 |
78 |
$269.54 |
| 82652 |
|
20 |
12 |
$232.40 |
| 73130 |
|
28 |
12 |
$219.20 |
| 82784 |
|
32 |
24 |
$210.71 |
| 84403 |
|
25 |
19 |
$187.02 |
| 80076 |
|
83 |
56 |
$168.42 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
132 |
71 |
$142.63 |
| 84436 |
|
24 |
12 |
$80.88 |
| 84146 |
|
16 |
13 |
$70.17 |
| 80069 |
|
21 |
12 |
$62.88 |
| 86706 |
|
20 |
12 |
$51.84 |
| 84702 |
|
18 |
13 |
$36.36 |
| 83550 |
|
136 |
83 |
$0.00 |
| 0352U |
|
18 |
14 |
$0.00 |